MedPath

Role Of Energy drinks in alertness.

Not Applicable
Registration Number
CTRI/2013/03/003512
Lead Sponsor
Vir Chandra Singh Garhwali Government Medical Science and research institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Normal healthy volunteers with no physical or laboratory abnormalities.

Exclusion Criteria

1)Significant uncontrolled systemic illness, i.e. diabetes, congestive heart failure, renal or hepatic disease.

2)History of consumption of anti inflammatory drugs for four weeks before starting the trial.

3)History of consumption of CNS affecting drugs for four weeks before starting the trial.

4)History of antioxidants or cognition enhancing substances for four weeks before starting the trial.

5)History of smoking and alcohol consumption for last four weeks.

6)Any intake of caffeinated drinks 48 hours prior to study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To investigate the role of taurine in modulating the state of inflammation produced due to acute sleep deprivation (acute stressor) in human participants. <br/ ><br>Timepoint: 25days
Secondary Outcome Measures
NameTimeMethod
To follow the effects of taurine in regulation of acute stress induced inflammation in relation to its impact on cognitive performance. <br/ ><br> <br/ ><br>To explore the action of taurine on glucose metabolism in acute stress. <br/ ><br> <br/ ><br>To report any unprecedented side effects which surface during the trial due to administration of taurine. <br/ ><br>Timepoint: three weeks
© Copyright 2025. All Rights Reserved by MedPath